Lipoprotein subfraction cholesterol distribution is more atherogenic in insulin resistant adolescents with type 1 diabetes

Adolescents with type 1 diabetes (T1D) often have a less atherogenic‐appearing fasting lipid profile than controls, despite increased rates of cardiovascular disease (CVD) as adults. We previously reported an atherogenic lipoprotein subfraction cholesterol distribution associated with insulin resistance (IR) in T1D adults. We sought to determine if T1D youth have more atherogenic profile than controls via a cross‐sectional study.

[1]  K. Nadeau,et al.  Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double‐blinded placebo‐controlled study , 2015, Pediatric diabetes.

[2]  S. Gidding,et al.  A randomized, double blind, placebo‐controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated low‐density lipoprotein cholesterol (LDL‐C) and type 1 diabetes , 2015, Pediatric diabetes.

[3]  R. Wadwa,et al.  Microvascular and macrovascular complications in children and adolescents , 2014 .

[4]  Diane Lacaille,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk , 2014 .

[5]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[6]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[7]  M. Jacobson,et al.  Non-HDL-cholesterol in an adolescent diabetes population. , 2014, Journal of clinical lipidology.

[8]  C. Saunders,et al.  Glycemic control and lipid profile of children and adolescents undergoing two different dietetic treatments for type 1 diabetes mellitus. , 2014, Nutricion hospitalaria.

[9]  J. de Sá,et al.  HDL cholesterol levels and weight are the main determinants of subclinical atherosclerosis in the young with type 1 diabetes and suitable glycaemic control , 2014, Diabetes & vascular disease research.

[10]  M. Flechtner-Mors,et al.  Carbohydrate intake in relation to BMI, HbA1c and lipid profile in children and adolescents with type 1 diabetes. , 2014, Clinical nutrition.

[11]  D. Dunger,et al.  Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes. , 2014, The Journal of clinical endocrinology and metabolism.

[12]  E. Ryan,et al.  De Novo Lipogenesis and Cholesterol Synthesis in Humans with Long-Standing Type 1 Diabetes Are Comparable to Non-Diabetic Individuals , 2013, PloS one.

[13]  D. Nathan,et al.  Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2013, Diabetes Care.

[14]  O. Youssef,et al.  Relation between carotid intima media thickness and oxidative stress markers in type 1 diabetic children and adolescents , 2013, Journal of Diabetes & Metabolic Disorders.

[15]  Amy S. Shah,et al.  Correlates of medical nutrition therapy and cardiovascular outcomes in youth with type 1 diabetes. , 2013, Journal of nutrition education and behavior.

[16]  Jennifer W Talton,et al.  Cardiovascular health in adolescents with type 1 diabetes: The SEARCH CVD Study , 2013, Pediatric diabetes.

[17]  R. Maranhão,et al.  Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment , 2013, Lipids in Health and Disease.

[18]  D. Maahs,et al.  Estimated insulin sensitivity and cardiovascular disease risk factors in adolescents with and without type 1 diabetes. , 2013, The Journal of pediatrics.

[19]  R. Beck,et al.  Most Youth With Type 1 Diabetes in the T1D Exchange Clinic Registry Do Not Meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines , 2013, Diabetes Care.

[20]  B. Zinman,et al.  The Effect of Excess Weight Gain With Intensive Diabetes Mellitus Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes Mellitus: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) Stu , 2013, Circulation.

[21]  T. Meroño,et al.  HOMA-IR and non-HDL-C as predictors of high cholesteryl ester transfer protein activity in patients at risk for type 2 diabetes. , 2012, Clinical biochemistry.

[22]  M. Rewers,et al.  Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes. , 2012, The Journal of clinical endocrinology and metabolism.

[23]  M. Rewers,et al.  Association of insulin sensitivity to lipids across the lifespan in people with Type 1 diabetes , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[24]  D. Maahs,et al.  Sugar-sweetened and diet beverage consumption is associated with cardiovascular risk factor profile in youth with type 1 diabetes , 2011, Acta Diabetologica.

[25]  M. Rewers,et al.  Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes study , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[26]  M. Rewers,et al.  Association of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication , 2010, Diabetologia.

[27]  H. Schatz,et al.  Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control , 2010, Diabetologia.

[28]  J. Hokanson,et al.  Lipoprotein Subfraction Cholesterol Distribution Is Proatherogenic in Women With Type 1 Diabetes and Insulin Resistance , 2010, Diabetes.

[29]  J. Regensteiner,et al.  Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. , 2010, The Journal of clinical endocrinology and metabolism.

[30]  R. Wadwa,et al.  Lipid and Lipoprotein Profiles in Youth With and Without Type 1 Diabetes , 2008, Diabetes Care.

[31]  M. Rewers,et al.  Dyslipidemia in youth with diabetes: to treat or not to treat? , 2008, The Journal of pediatrics.

[32]  G. Stephanopoulos,et al.  Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. , 2008, Cell metabolism.

[33]  J. Janosky,et al.  Longitudinal Study of Physiologic Insulin Resistance and Metabolic Changes of Puberty , 2006, Pediatric Research.

[34]  B. Paulweber,et al.  Cholesteryl Ester Transfer Protein in Metabolic Syndrome , 2006, Obesity.

[35]  D. Maahs,et al.  Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus. , 2005, The Journal of pediatrics.

[36]  J. Hokanson,et al.  Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. , 2005, Diabetes care.

[37]  S. Haffner,et al.  Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. , 2005, Metabolism: clinical and experimental.

[38]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[39]  A. J. Swerdlow,et al.  Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes , 2003, Diabetologia.

[40]  D. Lackland,et al.  Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. , 2003, Diabetes care.

[41]  M. Taskinen,et al.  Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. , 2002, Diabetes.

[42]  M. Rubens,et al.  The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. , 2000, Journal of the American College of Cardiology.

[43]  K. Forrest,et al.  Low-density lipoprotein particle size and coronary artery disease in a childhood-onset type 1 diabetes population. , 1999, Metabolism: clinical and experimental.

[44]  P A Cleary,et al.  Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. , 1998, JAMA.

[45]  L. Kuller,et al.  Coronary artery disease in IDDM. Gender differences in risk factors but not risk. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[46]  R. Eckel,et al.  Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[47]  Lipid and Lipoprotein Levels in Patients With IDDM: Diabetes Control and Complication Trial Experience , 1992, Diabetes Care.

[48]  T. Bulum,et al.  Insulin resistance in patients with type 1 diabetes: relationship with metabolic and inflammatory parameters. , 2013, Acta clinica Croatica.

[49]  Amy S. Shah,et al.  Glucose control predicts 2-year change in lipid profile in youth with type 1 diabetes. , 2013, The Journal of pediatrics.

[50]  Jennifer W Talton,et al.  Cardiovascular Risk Factors Are Associated With Increased Arterial Stiffness in Youth With Type 1 Diabetes , 2013, Diabetes Care.

[51]  P. Royle,et al.  Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control. Reply to Schatz H [letter] , 2010, Diabetologia.

[52]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.

[53]  R. Devries,et al.  Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus. , 2003 .

[54]  R. Dullaart,et al.  Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus. , 2003, Clinical laboratory.